Caption Guidance vs Cleerly ISCHEMIA
AI Verdict
Choose Caption Guidance if…
Choose Caption Guidance if your primary need is to empower healthcare providers to acquire high-quality cardiac ultrasound images, especially in settings where sonography expertise may be limited or real-time guidance is crucial. This tool is ideal for improving access to diagnostic-quality echocardiograms by assisting clinicians directly with probe manipulation and automated quality assessment during the scan.
View Caption Guidance →Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a non-invasive, AI-powered analysis of CCTA scans to determine the likelihood of coronary artery ischemia at a vessel level. This tool is best suited for detailed diagnosis and personalized treatment planning, providing insights into coronary plaque characteristics, stenosis severity, and fractional flow reserve estimation from existing CCTA data.
View Cleerly ISCHEMIA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Caption Guidance | Cleerly ISCHEMIA |
|---|---|---|
| Deployment | On-premise (integrated with ultrasound equipment) and cloud-based services. | Web-based solution |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Caption GuidanceCaption Guidance offers real-time AI guidance for ultrasound probe manipulation and automated quality assessment, directly assisting users during image acquisition. This integrated, interactive guidance within the workflow significantly enhances usability for performing complex cardiac ultrasounds, making the process more accessible and standardized.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA provides advanced, non-invasive analysis of CCTA scans, offering detailed insights into coronary artery ischemia likelihood, plaque characterization, and stenosis severity. Its ability to estimate fractional flow reserve (FFR) and provide comprehensive interactive reports directly aids in personalized diagnosis and treatment planning for heart disease, offering a more direct and advanced diagnostic capability for a specific, critical condition.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing details, indicating an enterprise-based or customized pricing model. Neither provides sufficient public information to assess their value proposition based on cost. Therefore, it is not possible to definitively pick a winner in this dimension.
Enterprise Readiness
Caption GuidanceBoth tools are FDA-cleared, HIPAA compliant, and have BAAs, demonstrating foundational enterprise readiness. However, Caption Guidance's integration as a software accessory into compatible GE HealthCare ultrasound systems (Venue Family, Vscan Air SL) suggests a more streamlined deployment and operational fit within existing imaging department workflows and hardware ecosystems of a major medical device company.
Innovation
Caption GuidanceCaption Guidance is highlighted as the 'first FDA-cleared AI-guided software' for real-time cardiac ultrasound image acquisition, representing a significant innovation in democratizing and standardizing diagnostic image capture at the point of care. While Cleerly ISCHEMIA offers highly innovative AI-powered CCTA analysis, Caption Guidance's pioneering approach to real-time acquisition guidance is a more foundational shift in the imaging workflow.
Support & Docs
Caption GuidanceWhile both companies offer support channels, Caption Guidance, as part of GE HealthCare, benefits from the extensive support infrastructure of a major medical device corporation. Documentation for related Caption products also indicates comprehensive support options, including 24/7 chat and priority support, suggesting a more robust and established support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Caption Guidance | Cleerly ISCHEMIA |
|---|---|---|
| Name | Caption Guidance | Cleerly ISCHEMIA |
| Primary Function | AI-guided software for acquiring diagnostic-quality cardiac ultrasound images with real-time guidance and automated quality assessment. | AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level. |
| Company | Caption Health (now part of GE HealthCare) | Cleerly |
| Imaging Modality | Cardiac Ultrasound | CCTA (Coronary CT Angiography) |
| Core AI Function | Real-time AI guidance for ultrasound probe manipulation and automated quality assessment. | AI-enabled CCTA analysis for non-invasive fractional flow reserve (FFR) estimation and vessel-level ischemia likelihood determination. |
| Key Output/Assessment | Automated quality assessment with a 'Quality Meter', auto-capture of diagnostic-quality ultrasound clips, automated ejection fraction calculation. | Vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), stenosis severity assessment, 3D digital models of coronary arteries. |
| Specialties | Cardiology, Critical Care, Radiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Caption Guidance and Cleerly ISCHEMIA.
Frequently Asked Questions
More Comparisons
More matchups featuring Caption Guidance or Cleerly ISCHEMIA
Backers
Who funded each tool's parent company.